MO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Altria Group Inc (MO) is not a strong buy for a beginner investor with a long-term strategy at this time. While the stock offers an attractive dividend yield of 6.1% and has seen some positive momentum in February, the company's recent financial performance shows significant declines in revenue, net income, and EPS. Additionally, technical indicators suggest a neutral to bearish trend in the short term, and there are no strong proprietary trading signals or recent influential trades to support immediate action. Given the investor's preference for long-term stability, it would be prudent to wait for clearer signs of recovery or better entry points.
The MACD is negative and expanding (-0.3), indicating bearish momentum. RSI is at 33.312, in the neutral zone but close to oversold territory. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading near its key support level of 66.785, suggesting limited upside in the short term.
Altria's dividend yield of 6.1% remains attractive for income-seeking investors.
Analysts have raised price targets recently, with some projecting a return to revenue growth and EPS acceleration in 2026-
The stock rose 11.4% in February due to strong consumer confidence.
Significant YoY declines in revenue (-0.53%), net income (-63.25%), and EPS (-63.13%) in Q4
MACD and RSI indicate weak momentum, and the stock is near its support level.
Analysts remain divided, with some maintaining an Underweight or Neutral rating.
Hedge funds and insiders show no significant trading activity, indicating a lack of strong institutional confidence.
In Q4 2025, revenue dropped to $5.08 billion (-0.53% YoY), net income dropped to $1.11 billion (-63.25% YoY), and EPS dropped to $0.66 (-63.13% YoY). Gross margin improved slightly to 71.06% (+0.68% YoY), but overall financial performance was weak.
Analyst sentiment is mixed. Barclays raised the price target to $63 but maintained an Underweight rating. UBS and BofA are more optimistic, with Buy ratings and price targets of $67 and $72, respectively. Stifel lowered its price target to $68 but kept a Buy rating. Citi raised its target to $65 with a Neutral rating.
